Idris Long | Diabetic Neuropathy | Best Researcher Award

Best Researcher Award

Idris Long
Universiti Sains Malaysia

Idris Long

Affiliation Universiti Sains Malaysia
Country Malaysia
Scopus ID 8307257200
Documents 47
Citations 593
h-index 12
Subject Area Diabetic Neuropathy
Event World Cell Biologist Awards
ORCID 0000-0002-6828-1908

Idris Long is a researcher affiliated with Universiti Sains Malaysia, Malaysia, whose academic profile is associated with the subject area of diabetic neuropathy. His research record includes 47 documents, 593 citations and an h-index of 12, according to the bibliometric information supplied for this profile. His academic recognition under the Best Researcher Award highlights research activity and scholarly contributions in a field relevant to diabetes-related neurological complications. [1]

Abstract

This academic profile presents the research background and bibliometric information of Idris Long, affiliated with Universiti Sains Malaysia. His stated subject area is diabetic neuropathy, a neurological complication associated with diabetes mellitus. Research in this area encompasses the investigation of nerve dysfunction, underlying biological mechanisms, clinical manifestations and potential therapeutic approaches. The supplied research metrics indicate 47 scholarly documents, 593 citations and an h-index of 12. These indicators provide a quantitative overview of the researcher’s publication and citation record. [1] [2]

Keywords

Idris Long; Best Researcher Award; Universiti Sains Malaysia; diabetic neuropathy; diabetes mellitus; neurological complications; biomedical research; research publications; citation analysis; scientific excellence.

Introduction

Diabetic neuropathy is a significant complication of diabetes mellitus and is characterized by damage or dysfunction of the peripheral nervous system. It can affect sensory, motor and autonomic nerve functions, with clinical manifestations varying according to the type and severity of nerve involvement. Scientific investigations into diabetic neuropathy contribute to a better understanding of disease mechanisms, diagnostic approaches, risk factors and therapeutic strategies. [3]

Research Profile

Idris Long is affiliated with Universiti Sains Malaysia, an academic institution in Malaysia. The researcher profile provided for this article identifies diabetic neuropathy as the relevant subject area. His bibliometric information, as supplied, includes the following indicators:

  • Institutional affiliation: Universiti Sains Malaysia.
  • Research subject: Diabetic Neuropathy.
  • Scopus Author ID: 8307257200.
  • Research documents: 47.
  • Total citations: 593.
  • h-index: 12.

These figures represent the bibliometric snapshot supplied for the article. Publication and citation counts may change over time as databases are updated and additional research outputs are indexed. [1] [2]

Research Contributions

The subject area of diabetic neuropathy encompasses several important research directions. These areas contribute to understanding the relationship between diabetes, metabolic disturbances and neurological dysfunction. Relevant scientific research themes include:

  • Pathophysiology of diabetic neuropathy: Investigation of biological and physiological processes associated with diabetes-related nerve damage.
  • Cellular and molecular mechanisms: Examination of cellular stress, oxidative damage, inflammatory responses and metabolic pathways involved in neurological complications.
  • Neurological assessment: Research into methods for evaluating peripheral nerve function and identifying neurological abnormalities.

Publications

The supplied Scopus profile reports 47 indexed research documents associated with the author identifier 8307257200. Scholarly publications provide a record of research dissemination and contribute to the exchange of scientific knowledge within academic communities. [1]

A detailed publication bibliography, including article titles, co-authors, journal names, publication years and digital object identifiers (DOIs), should be retrieved directly from the researcher’s indexed bibliographic records. Individual publication titles and DOIs have not been supplied for this article and are therefore not independently attributed to the researcher.

Research Impact

Bibliometric indicators are commonly used to describe aspects of scholarly publication and citation activity. The supplied figures for Idris Long indicate 593 citations across 47 research documents and an h-index of 12. The h-index represents a combination of publication productivity and citation impact, indicating that at least 12 publications have received 12 or more citations each, based on the database and date of measurement. [2]

Research concerning diabetic neuropathy has broader scientific relevance because it addresses neurological complications associated with a major chronic metabolic disorder. Continued investigation in this field can contribute to the development of improved understanding, assessment methods and therapeutic research strategies. [3]

Award Suitability

The Best Researcher Award recognizes researchers whose academic activities demonstrate research engagement, scholarly productivity and contributions to their respective disciplines. The profile of Idris Long presents a documented institutional affiliation, a defined subject area and the bibliometric figures supplied for consideration.

Conclusion

Idris Long’s academic profile reflects research activity associated with Universiti Sains Malaysia and the subject area of diabetic neuropathy. The supplied bibliometric indicators of 47 documents, 593 citations and an h-index of 12 provide a quantitative overview of the research record. The Best Researcher Award profile recognizes the importance of sustained scholarly activity and research engagement while emphasizing the value of continued contributions to scientific knowledge. Verification of publication records and award-specific assessment remains essential to a complete evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Idris Long, Author ID 8307257200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8307257200
  2. EY Abdo Qaid, Z Abdullah, R Zakaria, I Long. (2024). Minocycline mitigates tau pathology via modulating the TLR-4/NF-кβ signalling pathway in the hippocampus of neuroinflammation rat model.
    https://www.tandfonline.com/doi/abs/10.1080/01616412.2023.2296754
  3. NAM Khir, ASM Noh, I Long, et al. (2022). Inflammatory-associated apoptotic markers: are they the culprit to rheumatoid arthritis pain?.
    https://link.springer.com/article/10.1007/s11033-022-07591-y
  4. N Ab-Hamid, N Omar, CAN Ismail, I Long. (2023). Diabetes and cognitive decline: challenges and future direction.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10294066/
  5. EYA Qaid, I Long. (2025). Asthma unravelled: a comprehensive review of epidemiology, phenotypes, pathophysiology, and emerging therapies.
    https://link.springer.com/article/10.1186/s43168-025-00443-w

Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Prof. Dr. Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Aligarh Muslim University | India

Dr. Rizwan Hasan Khan is a distinguished professor at the Interdisciplinary Biotechnology Unit of Aligarh Muslim University, specializing in biophysical chemistry and molecular interactions related to protein aggregation and therapeutic drug design. With a Ph.D. awarded focused on lectins, Dr. Khan has significantly contributed to understanding protein fibrillation, aggregation mechanisms, and their inhibition, particularly in relation to amyloid diseases and antimicrobial resistance. His research encompasses the biophysical characterization of proteins, the impact of toxins and drugs on protein behavior, and the identification of novel inhibitors through computational and experimental approaches. Dr. Khan’s prolific output includes over 16 peer-reviewed research and review articles published in reputed journals such as Biophysical Chemistry, Archives of Biochemistry and Biophysics, and Cell Reports, reflecting interdisciplinary expertise in biotechnology, biochemistry, and drug discovery. His work has attracted citations highlighting its influence in the fields of amyloid research and therapeutic development. Dr. Khan maintains an h-index indicative of sustained scholarly impact, underscoring his role as a leading researcher in molecular biophysics and pharmacology. His research continues to advance knowledge in combating protein aggregation disorders and antimicrobial resistance, contributing valuable insights into novel drug candidates and molecular mechanisms.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu (II) flufenamate chemotherapeutic drug candidate”

  • “Ponceau 4R induces aggregation in human serum albumin and morin acts as an anti-aggregating agent against dye induced aggregates”

  • “Hippuric acid, a uremic toxin, binds to aggregation prone region of human lysozyme and potentiates the fibrillation: A biophysical insight”

  • “Identification of potential inhibitors of Ubiquitin carboxyl-terminal hydrolase 21 from repurposed drugs: Implications in anticancer therapeutics”

  • “Loss of Neurofibromin Induces Inflammatory Macrophage Phenotypic Switch and Retinal Neovascularization via GLUT1 Activation”

  • “Employing spectroscopic, calorimetric and structural bioinformatics approaches to decipher the binding mechanism of mangiferin with human transferrin”

  • “Interaction of Esculetin with Alpha-2-Macroglobulin: Biochemical and Biophysical Approaches”

  • “Utilizing non-β-lactam antibiotics to combat antimicrobial resistance by targeting multiple virulence factors of Pseudomonas aeruginosa”

  • “Strategies for inhibiting amyloid fibrillation: Current status and future prospects”

  • “Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies”